Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: Study protocol for a randomized controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  O'Meara, Eileen ^d   Mielniczuk, Lisa M ^a,b   Wells, George A ^a,b   deKemp, Robert A ^a,b   Klein, Ran ^a,b   Coyle, Doug ^b   Mc Ardle, Brian ^a,b   Paterson, Ian ^g   White, James A ^e   Arnold, Malcolm ^e   Friedrich, Matthias G ^d   Larose, Eric ^h   Dick, Alexander ^a,b,c   Chow, Benjamin ^a,b,c   Dennie, Carole ^a,b,c   Haddad, Haissam ^a,b   Ruddy, Terrence ^a,b   Ukkonen, Heikki ^f   Wisenberg, Gerald ^e   Cantin, Bernard ^h   Pibarot, Philippe ^h   Freeman, Michael ⁱ   Turcotte, Eric ^j   Connelly, Kim ^i,k   Clarke, James ^l   Williams, Kathryn ^a,b   Racine, Normand ^d   Garrard, Linda ^a,b   Tardif, Jean Claude ^d   DaSilva, Jean ^a,b   Knuuti, Juhani ^f   Beanlands, Rob ^a,b,c   more..

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d MONTREAL HEART INSTITUTE   (Canada)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSITY OF QUEBEC   (Canada)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j UNIVERSITÉ DE SHERBROOKE   (Canada)

^k SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^l DALHOUSIE UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ADULT; ALGORITHM; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE REGISTRY; HEART ARREST; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HOSPITAL READMISSION; HUMAN; INCIDENCE; INFORMED CONSENT; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MULTICENTER STUDY; PATIENT SAFETY; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARD;

ALGORITHMS; CANADA; CLINICAL PROTOCOLS; DIAGNOSTIC IMAGING; HEART ARREST; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PATIENT READMISSION; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; RESEARCH DESIGN; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84880129108     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-218     Document Type: Article

References (38)

1. Arnold JM, Liu P, Demers C, Dorian P, Giannetti N, Haddad H, Heckman GA, Howlett JG, Ignaszewski A, Johnstone DE, Jong P, McKelvie RS, Moe GW, Parker JD, Rao V, Ross HJ, Sequeira EJ, Svendsen AM, Teo K, Tsuyuki RT, White M. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006, 22:23-45. 10.1016/S0828-282X(06)70237-9, 2538984, 16450016.
2. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971, 285:1441-1446. 10.1056/NEJM197112232852601, 5122894.
3. Yatteau RF, Peter RH, Behar VS, Bartel AG, Rosati RA, Kong Y. Ischemic cardiomyopathy: the myopathy of coronary artery disease. Natural history and results of medical versus surgical treatment. Am J Cardiol 1974, 34:520-525. 10.1016/0002-9149(74)90121-0, 4278154.
4. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, Levine F, Schloss M. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983, 68:785-795. 10.1161/01.CIR.68.4.785, 6352078.
5. Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, Killip T, Mock MB, Pettinger M, Robertson TL. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990, 82:1629-1646. 10.1161/01.CIR.82.5.1629, 2225367.
6. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983, 51:831-836. 10.1016/S0002-9149(83)80141-6, 6681931.
7. Tu JV, Austin PC, Walld R, Roos L, Agras J, McDonald KM. Development and validation of the Ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol 2001, 37:992-997. 10.1016/S0735-1097(01)01109-3, 11263626.
8. Tjan TD, Kondruweit M, Scheld HH, Roeder N, Borggrefe M, Schmidt C, Schober O, Deng MC. The bad ventricle revascularization versus transplantation. Thorac Cardiovasc Surg 2000, 48:9-14.
9. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985, 312:1665-1671. 10.1056/NEJM198506273122603, 3873614.
10. Jones RH. Is it time for a randomized trial of surgical treatment of ischemic heart failure?. J Am Coll Cardiol 2001, 37:1210-1213. 10.1016/S0735-1097(01)01123-8, 11300424.
11. Doenst T, Velazquez EJ, Beyersdorf F, Michler R, Menicanti L, Di Donato M, Gradinac S, Sun B, Rao V. To STICH or not to STICH: we know the answer, but do we understand the question?. J Thorac Cardiovasc Surg 2005, 129:246-249. 10.1016/j.jtcvs.2004.07.060, 15678031.
12. Louie HW, Laks H, Milgalter E, Drinkwater DC, Hamilton MA, Brunken RC, Stevenson LW. Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation 1991, 84(5 Suppl):III290-III295.
13. Kron IL, Flanagan TL, Blackbourne LH, Schroeder RA, Nolan SP. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg 1989, 210:348-352. discussion 352-344, 10.1097/00000658-198909000-00011, 1358002, 2673084.
14. Hochberg MS, Parsonnet V, Gielchinsky I, Hussain SM. Coronary artery bypass grafting in patients with ejection fractions below forty percent. Early and late results in 466 patients. J Thorac Cardiovasc Surg 1983, 86:519-527.
15. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL, STICH Investigators Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011, 364:1607-1616. 10.1056/NEJMoa1100356, 3415273, 21463150, STICH Investigators.
16. Fang JC. Underestimating medical therapy for coronary artery disease... Again. N Engl J Med 2011, 364:1671-1673. 10.1056/NEJMe1103414, 21463151.
17. Beanlands RS, Chow BJ, Dick A, Friedrich MG, Gulenchyn KY, Kiess M, Leong-Poi H, Miller RM, Nichol G, Freeman M, Bogaty P, Honos G, Hudon G, Wisenberg G, Van Berkom J, Williams K, Yoshinaga K, Graham J. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summa. Can J Cardiol 2007, 23:107-119. 10.1016/S0828-282X(07)70730-4, 2650646, 17311116.
18. Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 2007, 32:375-410. 10.1016/j.cpcardiol.2007.04.001, 17560992.
19. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW, Laks H, Hawkins R, Schelbert HR, Phelps ME, Maddahi J. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994, 73:527-533. 10.1016/0002-9149(94)90327-1, 8147295.
20. D'Égiodio G, Nichol G, Williams KA, Guo A, Garrard L, deKemp R, Ruddy TD, DaSilva J, Humen D, Gulenchyn KY, Freeman M, Racine N, Benard F, Hendry P, Beanlands RS, PARR-2 Investigators Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging 2009, 2:1060-1068. 10.1016/j.jcmg.2009.02.017, 19761983, PARR-2 Investigators.
21. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986, 314:884-888. 10.1056/NEJM198604033141405, 3485252.
22. Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, Schoenhagen P, Starling RC, Flamm SD, Desai MY. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009, 2:34-44. 10.1016/j.jcmg.2008.09.010, 19356530.
23. Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 1998, 98(19 Suppl):II51-II56.
24. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SK, MacIntyre WJ, Thomas JD. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994, 90:2687-2694. 10.1161/01.CIR.90.6.2687, 7994809.
25. Yoshida K, Gould KL. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 1993, 22:984-997. 10.1016/0735-1097(93)90407-R, 8409073.
26. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002, 39:1151-1158. 10.1016/S0735-1097(02)01726-6, 11923039.
27. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, Garrard L, deKemp R, Guo A, Ruddy TD, Benard F, Lamy A, Iwanochko RM. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007, 50:2002-2012. 10.1016/j.jacc.2007.09.006, 17996568.
28. Abraham A, Nichol G, Williams K, Garrard L, Guo A, de Kemp RA, Davies RA, Duchesne L, Haddad H, Ruddy TD, Chow B, DaSilva J, Hendry P, Masters R, Higginson L, Beanlands RS. Ottawa-FIVE: FDG in viability evaluation at an experienced center with ready Access to FDG and integration with management teams. J Nucl Med 2010, 51:567-574. 10.2967/jnumed.109.065938, 20237039.
29. Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH, Panza JA, STICH Trial Investigators Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011, 364:1617-1625. 10.1056/NEJMoa1100358, 3290901, 21463153, STICH Trial Investigators.
30. Mielniczuk L, Beanlands R. Imaging-guided selection of patients with ischemic heart failure for high risk revascularization improves identification of those with the highest clinical benefit. Circ Cardiovasc Imaging 2012, 5:262-270. 10.1161/CIRCIMAGING.111.964668, 22438424.
31. Ziadi MC, Garrard L, Beanlands R, Chow B, Hessian R, Ruddy T, Guo A, Williams K, Davies RA, Renaud J, Etele J, DaSilva JN, Ficaro FP, Wisenberg G, Iwanachko M, Marriott C. FDG PET impacts positively management direction and predicts outcomes in a multicentre 'real world' setting. Circulation 2009, 120:S349. [abstract].
32. Liao L, Cabell CH, Jollis JG, Velazquez EJ, Smith WT, Anstrom KJ, Pappas PA, Ryan T, Kisslo JA, Landolfo CK. Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization. Am J Cardiol 2004, 93:1275-1279. 10.1016/j.amjcard.2004.01.071, 15135703.
33. Sawada SG, Dasgupta S, Nguyen J, Lane KA, Gradus-Pizlo I, Mahenthiran J, Feigenbaum H. Effect of revascularization on longterm survival in patients with ischemic left ventricular dysfunction and a wide range of viability. Am J Cardiol 2010, 106:187-192. 10.1016/j.amjcard.2010.03.014, 20599001.
34. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266.
35. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G, National Kidney Foundation National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147. 10.7326/0003-4819-139-2-200307150-00013, 12859163, National Kidney Foundation.
36. O'Meara E, Chong KS, Gardner RS, Jardine AG, Neilly JB, McDonagh TA. The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. Eur J Heart Fail 2006, 8:63-67. 10.1016/j.ejheart.2005.04.013, 16084759.
37. Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K. Estimating equations for glomerular filtration rate in the era of creatinine standardization: A systematic review. Ann Intern Med 2012, 156:785-795. 10.7326/0003-4819-156-11-201203200-00391, 22312131.
38. Schinkel AF, Poldermans D, Elhendy A, Bax JJ. Assessment of myocardial viability in patients with heart failure. J Nucl Med 2007, 48:1135-1146. 10.2967/jnumed.106.038851, 17574986.